Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Combo: DNA, protein & VLP vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2011-04-12 |
| Study Made Public: | 2011-08-08 |
Title
The induction of neutralising antibodies to HIV env proteins by modifications to gp41.
Description
CAVD 314 is a preclinical rabbit study investigating several prime-boost regimens in which HIV env gp160 protein and modified gp41 constructs were boosted with virus-like particles containing the corresponding modified gp41 proteins.
Sign in to see full information about this study and to download study data.
Products
CFA IFA CN54env-gp140 CTM-2F5 CTM CTM-H3 CTM-GCN-gp41 ZM96 GCN-gp41 FD VLP-GCN-gp41 CTM VLP-H3 CTM VLP-gp41 CTMIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.